Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

NEW YORK, December 31, 2025, 10:33 ET — Regular session Shares of Arcutis Biotherapeutics Inc rose 3.8% to $29.16 by 10:33 a.m. ET on Wednesday, extending gains in the final U.S. trading session of 2025. The Nasdaq-listed dermatology drugmaker traded between $28.08 and $29.19, with about 181,000 shares changing hands. The move puts ARQT within striking distance of $30 and about 8% below its 52-week high of $31.75, a level closely watched by momentum investors. The stock’s 52-week low stands at $11.14, according to market data. markets.businessinsider.com That relative strength mattered on a down day for risk assets. The biotech
31 December 2025
··
DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

Trump Media shares rose 4% to $13.05 Wednesday after announcing a digital token for shareholders, developed with Crypto.com. Each shareholder will be eligible for one non-cash, potentially non-transferable token per share, with rewards tied to Truth Social products. The announcement followed the launch of five Truth Social-branded ETFs on the NYSE a day earlier.
31 December 2025
···
New report puts Alabama Power coal ash ponds back under scrutiny near Mobile-Tensaw Delta

New report puts Alabama Power coal ash ponds back under scrutiny near Mobile-Tensaw Delta

Alabama Power is storing over 21 million tons of coal ash in an unlined pond at its James M. Barry plant on the Mobile River, according to an Inside Climate News investigation. The EPA finalized a settlement in 2024 requiring more groundwater monitoring at the site after alleged violations. Alabama Power says it complies with regulations. A lawsuit over the plant’s closure plan is pending at the 11th Circuit.
31 December 2025
·
FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation shares fell 0.5% to $196.72 premarket after launching FTAI Power, a unit converting CFM56 jet engines into 25-megawatt turbines for data centers. The company expects production to start in 2026, aiming to deliver over 100 turbines per year. The stock had surged 14.4% in the previous session. Jefferies said the platform could become a major earnings driver if scaled.
31 December 2025
··
Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx shares slipped 0.2% to $22.74 premarket Wednesday after plunging 43.5% Monday on failed Phase 3 trial results for setrusumab in osteogenesis imperfecta. The company said it will cut expenses and shift focus to its DTX401 gene therapy, for which it completed a rolling FDA application. Senior VP Theodore Huizenga sold 85 shares on Dec. 29 to cover taxes. Investors await further details on cost reductions and regulatory milestones.
31 December 2025
·
Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

NEW YORK, December 31, 2025, 08:41 ET — Premarket Ambev S.A. shares were down 0.8% at $2.461 in premarket trading, after ending Tuesday up 2.5% at $2.48. The ADR has traded between $2.28 and $2.60 in recent sessions, reflecting choppy year-end positioning. StockAnalysis The timing matters because late-December trading can amplify small flows, especially in high-yield stocks where investors are repositioning around payouts. For Ambev, the week’s dividend schedule has been the main company-specific marker on screens. Ambev told investors in a U.S. securities filing that its board approved dividends of 0.4612 reais per share, “to be made on December
31 December 2025
·
Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital shares rose about 1% to $24.31 premarket Wednesday after a non-binding term sheet proposed combining its cloud unit with Ekso Bionics to form ChronoScale. Applied Digital would own 97% of the new company if the deal closes, expected in the first half of 2026. Investors await further deal details and the Jan. 7 earnings report. The stock closed Tuesday at $24.08, down 2.9%.
31 December 2025
····
B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold shares edged up 0.1% to $4.56 in premarket trading Wednesday, tracking a 0.9% drop in spot gold as profit-taking and higher futures margins weighed on bullion. Gold remains up about 65% for the year. B2Gold reported third-quarter production of 254,369 ounces and all-in sustaining costs of $1,479 per ounce. U.S. markets faced thin holiday trading and lower index futures ahead of the final 2025 session.
31 December 2025
··
Transocean stock today nudges higher in premarket after Australia drilling update

Transocean stock today nudges higher in premarket after Australia drilling update

Transocean shares rose 0.2% to $4.14 in premarket trading Wednesday after closing at $4.13. Oil prices were steady, with Brent at $61.54 and WTI at $58.16, but both were set for annual losses over 15%. ConocoPhillips paused drilling at the Charlemont-1 well in Australia after unexpected gas shows using a Transocean rig. U.S. jobless claims fell to 199,000 for the week ended Dec. 27.
31 December 2025
··
Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour shares hovered near $5 premarket Wednesday after Fairfax Financial disclosed it bought about 15.7 million shares across two classes in late December. Fairfax and affiliates now own over 30 million Class A shares, or 16.1% of that class. The purchases totaled roughly $71 million at prices between $4.36 and $4.73. Investors await Under Armour’s next quarterly update in early 2026.
31 December 2025
··
BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai shares fell 3.2% to $5.50 in premarket trading after the company postponed a shareholder vote on doubling its authorized common stock to Jan. 22. CEO Kevin McAleenan told investors the company is running low on authorized shares. The board is seeking more support for the proposal, which would raise the limit to 1 billion shares. The Ask Sage acquisition is expected to close late Q4 2025 or early Q1 2026.
31 December 2025
·
Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab shares rose 0.9% to $71.07 in premarket trading Wednesday after closing at $70.45 Tuesday. Director Edward H. Frank sold 2,500 shares at $77.39 and gifted 5,000 shares, according to an SEC filing. The company recently won an $816 million U.S. Space Development Agency contract for 18 missile-tracking satellites. Rocket Lab completed its final 2025 launch on Dec. 21, deploying a Japanese satellite.
31 December 2025
·
1 … 283 284 285 286 287 … 535

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop